Final analysis of camrelizumab plus chemotherapy for untreated advanced or metastatic esophageal squamous cell carcinoma: The ESCORT-1st trialMing-Ming He, Hui Luo, Teng Mao et al.|Med|2024Cited by 32
[Responses of advanced esophageal cancer to chemotherapy and prognostic factors: a report of 138 cases].Aina Liu, Jinwan Wang, Jing Huang et al.|PubMed|2008Cited by 1